Primary Retroperitoneal DOG-1 Positive & P16 Negative Squamous Cell Carcinoma in a Male – A Rare Case Report

Case Report

Authors

  • Neda Ahsan Department of Pathology, Central Hospital, South Eastern Railway, Garden Reach, Kolkata, West Bengal, India
  • Mahamaya Sharma Department of Pathology, Central Hospital, South Eastern Railway, Garden Reach, Kolkata, West Bengal, India

DOI:

https://doi.org/10.56501/intjhistopatholinterpret.v13i2.1145

Keywords:

DOG-1, P16, Immunohistochemistry, Squamous cell carcinoma , Retroperitoneum

Abstract

Retroperitoneal neoplasms represent a rare subset of tumors, accounting for only 0.1–0.2% of all cancers. Among them, squamous cell carcinoma (SCC) arising in the retroperitoneal cavity is exceedingly rare, with limited understanding of its pathogenesis and clinical features. Here, a case of primary retroperitoneal squamous cell carcinoma is reported in a male patient who presented with complains of abdominal pain and recurrent diarrhea. On radiological imaging, a large, heteroechoic mass with necrotic components enveloping the celiac trunk in the retroperitoneal region was noted. Histopathological assessment of a core biopsy confirmed a malignant tumor with large atypical cells in clusters with moderate to marked nuclear pleomorphism, prominent nucleoli and abundant eosinophilic to clear cytoplasm. An immunohistochemical (IHC) panel, including markers such as Epithelial Membranous Antigen (EMA), PanCK, CK7, CK20, DOG-1, CD117, β-Catenin, SOX10, CD10, SMA, S100, CEA, TTF-1, CDX2, HMB45, p16, p53, p40 and p63 was systematically conducted for further characterization. Based on the Immunohistochemical (IHC) results, a myriad of differentials were ruled out and the diagnosis of primary retroperitoneal squamous cell carcinoma with DOG1 positivity and P16 negativity was established. Based on extensive research conducted on PubMed, Scopus, and Google Scholar, it appears that this case could potentially be the first documented instance of a male patient with primary retroperitoneal squamous cell carcinoma exhibiting positive DOG1 and negative p16.

References

Neville A, Herts BR. CT Characteristics of Primary Retroperitoneal Neoplasms. Critical Reviews in Computed Tomography. 2004; 45(4):247–70. DOI: 10.3109/10408370490506616. https://pubmed.ncbi.nlm.nih.gov/15554383/

Rajiah P, Sinha R, Cuevas C, Dubinsky TJ, Bush WH, Kolokythas O. Imaging of Uncommon Retroperitoneal Masses. Radiographics. 2011; 31(4):949–76. DOI: 10.1148/rg.314095132. https://pubmed.ncbi.nlm.nih.gov/21768233/

Yan W, Wistuba II, Emmert-Buck MR, Erickson HS. Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites. Am. J. Cancer Res 2011;1(3):275–300. DOI:10.1158/1538-7445.am2011-275. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175764/

Pandey A, Kumar D, Gupta P, Khosla D, Periasamy K, Kapoor R. Primary retroperitoneal squamous cell carcinoma: a literature review. J . Cancer Res Clin Oncol. 2023; 149(13):12507-12512. DOI: 10.1007/s00432-023-04969-8. https://pubmed.ncbi.nlm.nih.gov/37353604/

Isbell A, Fields EC. Three cases of women with HPV-related squamous cell carcinoma of unknown primary in the pelvis and retroperitoneum: A case series. Gynecol. Oncol. Rep. 2016 Apr; 16:5–8. DOI: 10.1016/j.gore.2016.01.005. https://pubmed.ncbi.nlm.nih.gov/27331126/

Matsuzaka Y, Yamaguchi K, Koki Moriyoshi, Takao Y, Kenji Takakura, Konishi I. Primary retroperitoneal squamous cell carcinoma: a case report with review of the literature. Int. Canc. Conf.J.2019;8(2):61–5.DOI:10.1007/s13691-018-00354-2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498350/

Zhou G, Liu Z, Myers JN. TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response. J. Cell. Biochem. 2016;117(12):2682–92. DOI: 10.1002/jcb.25592 https://pubmed.ncbi.nlm.nih.gov/27166782/

Wee-Stekly WW, Mueller MD. Retroperitoneal Tumors in the Pelvis: A Diagnostic Challenge in Gynecology. Front. Surg. 2014;1:7-9. DOI: 10.3389/fsurg.2014.00049 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286971/

Brennan C, Kajal D, Khalili K, Ghai S. Solid malignant retroperitoneal masses—a pictorial review. Insights Imaging. 2014; 5(1):53–65. DOI: 10.1007/s13244-013-0294-0. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948907/

Jansen K, Farahi N, Büscheck F, Lennartz M, Luebke AM, Burandt E, et al. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples. JPRP. 2021; 228:153663. DOI: 10.1016/j.prp.2021.153663 https://pubmed.ncbi.nlm.nih.gov/34717148/

Fiorentino V, Patrizia Straccia, Tralongo P, Musarra T, Pierconti F, Martini M, et al. DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2022 Aug 26;23(17):9711–1. DOI: 10.3390/ijms23179711 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456024/

Downloads

Published

2024-08-27

How to Cite

Ahsan, N., & Sharma, M. (2024). Primary Retroperitoneal DOG-1 Positive & P16 Negative Squamous Cell Carcinoma in a Male – A Rare Case Report: Case Report. International Journal of Histopathological Interpretation, 13(2), 10–16. https://doi.org/10.56501/intjhistopatholinterpret.v13i2.1145